Finasteride therapy does not significantly alter the percent free PSA value but decreases free and total serum PSA concentrations by fifty percent

被引：0
|
作者：
Giacherio, DA
Wojno, KJ
Beduschi, MC
England, BG
Oesterling, JE
Gormley, GJ
Bach, MA
Waldstreicher, J
机构：
[1] UNIV MICHIGAN,ANN ARBOR,MI 48109
[2] MERCK & CO INC,RAHWAY,NJ 07065
来源：
CLINICAL CHEMISTRY | 1997年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：606 / 606
页数：1
相关论文
共 50 条
  • [41] Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age
    Partin, AW
    Catalona, WJ
    Southwick, PC
    Subong, ENP
    Gasior, GH
    Chan, DW
    UROLOGY, 1996, 48 (6A) : 55 - 61
  • [42] Correlation of prostate volume and percent free PSA in prostate cancer detection in men with a total PSA 2.6-10.0 ng/ml
    Bruno, JJ
    Armenakas, NA
    Fracchia, JA
    JOURNAL OF UROLOGY, 2006, 175 (04): : 478 - 479
  • [43] Accuracy of percent free PSA to predict prostate cancer diagnosis in men with total PSA ranges lower than 2.5 ng/ml
    Haese, A.
    Walz, J.
    Gallina, A.
    Steuber, T.
    Briganti, A.
    Chun, F.
    Graefen, M.
    Montorsi, F.
    Huland, H.
    Karakiewicz, P. I.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 50 - 50
  • [44] Cost-effectiveness of percent free PSA for prostate cancer detection in Chinese men with a total PSA of 4.0-10.0 ng/ml
    Yuhung, A. L.
    BJU INTERNATIONAL, 2015, 115 : 9 - 9
  • [45] An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: Results on 4298 cases
    Carlson, GB
    Calvanese, CB
    Partin, AW
    UROLOGY, 1998, 52 (03) : 455 - 461
  • [46] Impact of total PSA and percent free PSA in the differentiation of prostate disease: a retrospective comparative study implicating neoplastic and non-neoplastic entities
    Vezyraki, Patra
    Vlachaki, Angeliki
    Baltogiannis, Dimitrios
    Batistatou, Anna
    Tsampalas, Stavros
    Simos, Yannis, V
    Kaltsas, Aris
    Pappas, Periklis
    Dounousi, Evangelia
    Ragos, Vasilios
    Tsiambas, Evangelos
    Peschos, Dimitrios
    JOURNAL OF BUON, 2019, 24 (05): : 2107 - 2113
  • [47] Clinical utility of PROPSA and BPSA when percent free PSA is below 15%
    Partin, AW
    Mangold, LA
    Sokoll, LJ
    Chan, DW
    Mikolajczyk, SD
    Linton, HJ
    Evans, CL
    Rittenhouse, HG
    JOURNAL OF UROLOGY, 2003, 169 (04): : 384 - 384
  • [48] ECONOMIC EVALUATION OF PERCENT FREE PSA FOR PROSTATE CANCER DETECTION IN TAIWANESE MEN
    Lai, A. Y. H.
    VALUE IN HEALTH, 2014, 17 (07) : A469 - A469
  • [49] Comparison of plasma to serum results for the Abbott ARCHITECT® total PSA and free PSA assays
    Nutter, M.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A172 - A172
  • [50] A comparison of six commercial assays for total and free prostate specific antigen (PSA): the predictive value of the ratio of free to total PSA
    Patel, D
    White, PAE
    Ward, AM
    BJU INTERNATIONAL, 2000, 85 (06) : 686 - 689
12345